Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning

NCT06789419 is registered in ClinicalTrials.gov with Beijing Children's Hospital as lead sponsor.

NCT NCT06789419
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06789419 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Predicting Epileptogenic Tubers in Patients with Tuberous Sclerosis Complex Using a Fusion Model Integrating Lesion Network Mapping and Machine Learning
Lead sponsor
Beijing Children's Hospital
Phase
Observational
Overall status
Completed
Start date
July 1, 2016
Completion date
June 1, 2023
Enrollment
112 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

tuberous sclerosis complex